Literature DB >> 34934111

Fractal-fractional and stochastic analysis of norovirus transmission epidemic model with vaccination effects.

Ting Cui1, Peijiang Liu2,3, Anwarud Din4.   

Abstract

In this paper, we investigate an norovirus (NoV) epidemic model with stochastic perturbation and the new definition of a nonlocal fractal-fractional derivative in the Atangana-Baleanu-Caputo (ABC) sense. First we present some basic properties including equilibria and the basic reproduction number of the model. Further, we analyze that the proposed stochastic system has a unique global positive solution. Next, the sufficient conditions of the extinction and the existence of a stationary probability measure for the disease are established. Furthermore, the fractal-fractional dynamics of the proposed model under Atangana-Baleanu-Caputo (ABC) derivative of fractional order "[Formula: see text]" and fractal dimension "[Formula: see text]" have also been addressed. Besides, coupling the non-linear functional analysis with fixed point theory, the qualitative analysis of the proposed model has been performed. The numerical simulations are carried out to demonstrate the analytical results. It is believed that this study will comprehensively strengthen the theoretical basis for comprehending the dynamics of the worldwide contagious diseases.
© 2021. The Author(s).

Entities:  

Mesh:

Year:  2021        PMID: 34934111      PMCID: PMC8692620          DOI: 10.1038/s41598-021-03732-8

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  14 in total

1.  A norovirus outbreak in a nursing home: norovirus shedding time associated with age.

Authors:  Chao-Chih Lai; Ying-Hsueh Wang; Ching-Yi Wu; Ching-Hsiang Hung; Donald Dah-Shyong Jiang; Fang-Tzy Wu
Journal:  J Clin Virol       Date:  2012-11-13       Impact factor: 3.168

2.  Prolonged norovirus shedding in infants <or=6 months of age with gastroenteritis.

Authors:  Toshio Murata; Noriko Katsushima; Katsumi Mizuta; Yasushi Muraki; Seiji Hongo; Yoko Matsuzaki
Journal:  Pediatr Infect Dis J       Date:  2007-01       Impact factor: 2.129

3.  Norovirus infections and seroprevalence of genotype GII.4-specific antibodies in a Spanish population.

Authors:  Noelia Carmona-Vicente; Manuel Fernández-Jiménez; Juan M Ribes; Carlos J Téllez-Castillo; Parisá Khodayar-Pardo; Jesús Rodríguez-Diaz; Javier Buesa
Journal:  J Med Virol       Date:  2015-04       Impact factor: 2.327

4.  Mathematical modelling of the impact of treating latent tuberculosis infection in the elderly in a city with intermediate tuberculosis burden.

Authors:  Ka Chun Chong; Chi Chiu Leung; Wing Wai Yew; Benny Chung Ying Zee; Greta Chun Huen Tam; Maggie Haitian Wang; Katherine Min Jia; Pui Hong Chung; Steven Yuk Fai Lau; Xiaoran Han; Eng Kiong Yeoh
Journal:  Sci Rep       Date:  2019-03-19       Impact factor: 4.379

5.  A new mathematical model of COVID-19 using real data from Pakistan.

Authors:  Olumuyiwa James Peter; Sania Qureshi; Abdullahi Yusuf; Mohammed Al-Shomrani; Abioye Abioye Idowu
Journal:  Results Phys       Date:  2021-03-31       Impact factor: 4.476

Review 6.  A systematic review and meta-analysis of the global seasonality of norovirus.

Authors:  Sharia M Ahmed; Benjamin A Lopman; Karen Levy
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

7.  Norovirus disease in the United States.

Authors:  Aron J Hall; Ben A Lopman; Daniel C Payne; Manish M Patel; Paul A Gastañaduy; Jan Vinjé; Umesh D Parashar
Journal:  Emerg Infect Dis       Date:  2013-08       Impact factor: 6.883

8.  Prediction of Treatment Response for Combined Chemo- and Radiation Therapy for Non-Small Cell Lung Cancer Patients Using a Bio-Mathematical Model.

Authors:  Changran Geng; Harald Paganetti; Clemens Grassberger
Journal:  Sci Rep       Date:  2017-10-19       Impact factor: 4.379

9.  The Complex Dynamics of Hepatitis B Infected Individuals with Optimal Control.

Authors:  Anwarud Din; Yongjin Li; Murad Ali Shah
Journal:  J Syst Sci Complex       Date:  2021-02-04       Impact factor: 1.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.